In a market that continues to challenge investors with its volatility, Neuberger Berman High Yield Strategies Fund (NHS) has marked a new 52-week low, with its stock price dipping to $7.51. This latest price point reflects the ongoing adjustments in the investment landscape, as the fund navigates through economic headwinds. The fund currently offers an attractive 14.3% dividend yield and has maintained dividend payments for 16 consecutive years, according to InvestingPro data. Despite the downward pressure, NHS has delivered a robust YTD return of 12.4% and a 1-year total return of 14.3%. This resilience in the face of a tough market environment underscores the fund's strategic efforts to adapt and seek out yield opportunities for its investors, even as it hits a new annual low. With a beta of 0.96, the fund demonstrates relatively stable market correlation. Unlock more insights and 3 additional ProTips with InvestingPro.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.